Results 111 to 120 of about 63,989 (248)

Early Mobilization After Pacemaker Implantation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The increasing use of cardiac implantable electronic devices (CIED) is leading to a rise in procedure‐related complications. Objective This trial aimed to assess the safety and feasibility of early mobilization and the possibility of same‐day discharge following permanent pacemaker implantation.
Jiří Šmíd, Vlastimil Vančura, Martin Brada, Richard Rokyta   +3 more
wiley   +1 more source

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Blood Advances, 2020
Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard anticoagulants in the predefined subgroup of children with cerebral venous ...
P. Connor, M. Sánchez van Kammen, A. Lensing, E. Chalmers, K. Kállay, Kerry M Hege, P. Simioni, T. Biss, F. Bajolle, D. Bonnet, S. Grunt, Riten Kumar, O. Lvova, R. Bhat, An Van Damme, J. Palumbo, A. Santamaría, P. Saracco, J. Payne, S. Baird, K. Godder, V. Labarque, C. Male, I. Martinelli, Michelle Morales Soto, J. Motwani, Sanjay Shah, H. L. Hooimeijer, M. Prins, D. Kubitza, William T. Smith, S. Berkowitz, Á. Pap, Madhurima Majumder, P. Monagle, J. Coutinho   +35 more
semanticscholar   +1 more source

Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive procedures

Transfusion, EarlyView.
Abstract Background Oral factor Xa (FXa) inhibitors are anticoagulants with no approved reversal agent for use before urgent invasive procedures. Four‐factor prothrombin complex concentrate (4F‐PCC) is used off‐label for this despite limited evidence regarding its effectiveness and safety.
Mohammad Shamiea, Alex Osnis, Awan Kashoua, Orli Avnery, Gilad Itchaki, Shuli Isman, Tali Tohami, Osnat Jarchowsky‐Dolberg, Martin Ellis   +8 more
wiley   +1 more source

ESVM Guideline on peripheral arterial disease [PDF]

, 2019
International ...
, , , Belch, Jill, Boc, Vinko, Brodmann, Marianne, Bulvas, Miroslav, Canning, Caitriona, Carpentier, Patrick H., Chraim, Ali, Colgan, Mary-Paula, Dimakakos, Evangelos, Dorigo, Walter, Frank, Ulrich, Gottsäter, Anders, Heiss, Christian, Houston, Graeme, Kahan, Thomas, Lawall, Holger, Lindstedt, Isak, Madaric, Juraj, Mahe, Guillaume, Martini, Romeo, Mazzolai, Lucia, Nikol, Sigrid, Olinic, Dan Mircea, Pernod, Giles, Poredoš, Pavel, Przywara, Stanislaw, Pécsvárady, Zsolt, Quéré, Isabelle, Righini, Marc, Roztocil, Karel, Schlager, Oliver, Stanek, Agata, Terlecki, Piotr, Vasic, Dragan, Visonà, Adriana, Wautrecht, Jean-Claude   +38 more
core   +5 more sources

Branch retinal artery occlusion due to patent foramen ovale in a teenager

Experimental Physiology, EarlyView.
Abstract This report demonstrates the diagnostic evaluation and clinical management of a 16‐year‐old girl who developed branch retinal artery occlusion secondary to patent foramen ovale. The goal is to increase awareness of this rare presentation in adolescents among clinicians, with a summary of the important clinical features, multimodal imaging ...
Jie Zu, Fang Fan, Jiayao Wang, Jianmin Wang, Zhiyang Jia   +4 more
wiley   +1 more source

Using electronic health records to support clinical trials: a report on stakeholder engagement for EHR4CR [PDF]

, 2015
Background. The conduct of clinical trials is increasingly challenging due to greater complexity and governance requirements as well as difficulties with recruitment and retention.
Dugas, Martin, Ford, Ian, Kalra, Dipak, Mccowan, Colin, Prokosch, Hans-Ulrich, Sullivan, Frank M., Szmigielski, Cezary A., Thomson, Elizabeth   +7 more
core   +6 more sources

Rivaroxaban-induced hemorrhage associated with ABCB1 genetic defect

Frontiers in Pharmacology, 2016
We report a patient who presented a non-ST segment elevation myocardial infarction in the context of severe normocytic hypochromic anemia related to gastrointestinal bleeding, three months after switching anticoagulant from the vitamin K antagonist ...
Kuntheavy Ing Lorenzini, Youssef Daali, Pierre Fontana, Jules Desmeules, Caroline Flora Samer   +4 more
doaj   +1 more source

Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital

Australasian Journal on Ageing, Volume 45, Issue 2, June 2026.
ABSTRACT Objective Apixaban is widely recommended as first line therapy for atrial fibrillation (AF) and venous thromboembolism (VTE). Despite the widespread availability of dosing guidelines, anecdotal evidence suggests clinicians do not routinely follow these recommendations. Inappropriate dose reduction is associated with suboptimal patient outcomes.
Katherine J. Creeper, Grace Lenaghan, Aaron Stockwell, Matthew Schmidt, Katharine Ingram, Andrew C. Stafford   +5 more
wiley   +1 more source

PHC9 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN THE UK [PDF]

, 2008
Vitis vinifera cell cultures respond to pathogens and elicitors by synthesizing and extracellularly accumulating stilbenoid phytoalexins. Large amounts of trans-resveratrol (t-R) are produced when a cell culture is elicited with methylated cyclodextrins (
Adrian, Adrian, Ageorges, Alcaraz, Alfenito, Almagro, Almagro, Bartholomew, Batoko, Bavaresco, Bavaresco, Belchí-Navarro, Belchí-Navarro, Belhadj, Boyko, Browman, Bru, Calderon, Chen, Coleman, Conn, Derckel, Dixon, Dixon, Dixon, Earley, Edwards, Ferri, Flury, Francisco, García-Florenciano, Gomez, Grotewold, Götz, Hall, Hoos, Jaillon, Jeandet, Kitamura, Koncz, Kotakis, Krisa, Langcake, Li, Lijavetzky, Liswidowati, Maniatis, Marrs, Martínez-Esteso, Martínez-Esteso, Martínez-Esteso, Martínez-Esteso, Martínez-Márquez, Martínez-Márquez, Moons, Morales, Morante-Carriel, Mueller, Mueller, Nelson, Pezet, Pérez-Díaz, Qi, Qi, Raghupathi, Reid, Sambrook, Schmidlin, Siemann, Staron, Sturn, Sun, Tassoni, Vang, Velasco, Waldeck, Xie, Yazaki, Yue, Zamboni, Zettl, Zhao   +81 more
core   +4 more sources

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation

Therapeutics and Clinical Risk Management, 2014
Alexander GG Turpie Department of Medicine, McMaster University, Hamilton, ONT, Canada Abstract: Atrial fibrillation (AF) is the most common cardiac arrhythmia in the developed world and is associated with a fivefold increase in the risk of stroke ...
Turpie AGG
doaj